Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas.

Abstract

Our results indicate that the treatment of cholangiocarcinomas with gemcitabine is effective and should be further evaluated in phase III studies. In contrast, palliative chemotherapy with gemcitabine cannot be recommended in patients with hepatocellular carcinoma and liver cirrhosis.